CD24−/CD44+ tumor cells or ALDH1-positive tumor cells were significantly associated with poor survival in a recent meta-analysis (Zhou et al. 2010), although ALDH1 expression alone does not significantly predict outcomes (Neumeister et al. 2010). This evidence concerns the gene ALDH1A1 and neoplasm.